Oppenheimer Reaffirms Outperform Rating for Harmony Biosciences (NASDAQ:HRMY)
Oppenheimer reiterated their outperform rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $59.00 price target on the stock, up from their previous price target of $56.00. A number of other research firms also recently issued reports on HRMY. […]
More Stories
The Gentlemen Season 2 is Airing: Know About the Plot, Episodes, and Cast
Eddie has returned with season 2 of The Gentlemen. This time, his appearance and costumes reflect his new life as...
LEGO ONE PIECE is Live! Where to Watch and Full Cast Updates
Good news for Straw Hats fans who were waiting for the release of LEGO ONE PIECE Season 3. No, its...
Rebel Moon 3: Release Date, Cast Members, and Production Details
Zack Snyder has finally spoken about the release of Rebel Moon 3 after the release of the second sequel in...
Is Crew Girl Renewed for Season 2? Release Date, Cast, and Production Details
Are you also a fan of Canadian drama? Miku and Kyle’s duo is returning with Crew Girl Season 2. It...
The Four Seasons Season 3: Release Date, Cast, Episodes, and More
Looking for an upcoming American romantic-comedy drama series? Good news! The popular friendship-based series is coming back. The Four Seasons...
Take Charge of My Heart: Release Date, Trailer, Plot, and More
Are you also hunting for the next Korean romantic-comedy drama? Then your search ends here. Take Charge of My Heart...